Paper772175
Bromocriptine treatment in Parkinson's disease.
Parkes JD and 6 others. J Neurol Neurosurg Psychiatry, 1976. Cited by 89 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bromocriptine treatment in Parkinson's disease. Papers, record 772175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/772175
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ergolines | Major topic |
| Parkinson Disease | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Female | |
| Growth Hormone | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,213,659 | A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA. | Nature | 1964 | https://conductscience.org/library/papers/14213659 | PubMed |
| 2 | 4,563,448 | Injected apomorphine and orally administered levodopa in Parkinsonism. | Arch Neurol | 1972 | https://conductscience.org/library/papers/4563448 | PubMed |
| 3 | 4,425,916 | Bromocriptine in Parkinsonism. | Br Med J | 1974 | https://conductscience.org/library/papers/4425916 | PubMed |
| 4 | 4,402,038 | Evidence for a new type of dopamine receptor stimulating agent. | J Pharm Pharmacol | 1971 | https://conductscience.org/library/papers/4402038 | PubMed |
| 5 | 166,332 | Studies on the antiparkinsonism efficacy of lergotrile. | Neurology | 1975 | https://conductscience.org/library/papers/166332 | PubMed |
| 6 | 4,146,398 | Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. | J Pharm Pharmacol | 1973 | https://conductscience.org/library/papers/4146398 | PubMed |
| 7 | 4,371,345 | Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy. | J Clin Endocrinol Metab | 1974 | https://conductscience.org/library/papers/4371345 | PubMed |
| 8 | 4,383,150 | Evidence for dopamine receptor stimulation by apomorphine. | J Pharm Pharmacol | 1967 | https://conductscience.org/library/papers/4383150 | PubMed |
| 9 | 4,691,682 | Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase. | J Neurol Neurosurg Psychiatry | 1973 | https://conductscience.org/library/papers/4691682 | PubMed |
| 10 | 4,672,297 | The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). | J Clin Endocrinol Metab | 1972 | https://conductscience.org/library/papers/4672297 | PubMed |
| 11 | 4,901,383 | Similarities between neurologic effects of L-dopa and of apomorphine. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4901383 | PubMed |
| 12 | 1,112,876 | Apomorphine: effect on growth hormone. | J Clin Endocrinol Metab | 1975 | https://conductscience.org/library/papers/1112876 | PubMed |
| 13 | 1,117,050 | Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine. | J Clin Endocrinol Metab | 1975 | https://conductscience.org/library/papers/1117050 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,819,290 | Artificial intelligence and multiomics integration for Parkinson's disease drug development. | Mol Cells | 2026 | https://conductscience.org/library/papers/41819290 | PubMed |
| 41,009,387 | Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009387 | PubMed |
| 39,718,740 | Bromocriptine Versus Levodopa and other treatments in Parkinson's Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials. | Acta Neurol Belg | 2025 | https://conductscience.org/library/papers/39718740 | PubMed |
| 38,225,264 | Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. | Nat Rev Neurol | 2024 | https://conductscience.org/library/papers/38225264 | PubMed |
| 36,932,180 | Psychedelics: preclinical insights provide directions for future research. | Neuropsychopharmacology | 2024 | https://conductscience.org/library/papers/36932180 | PubMed |
| 35,711,802 | Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/35711802 | PubMed |
| 33,571,431 | Structural insights into the human D1 and D2 dopamine receptor signaling complexes. | Cell | 2021 | https://conductscience.org/library/papers/33571431 | PubMed |
| 32,476,098 | Botanical Therapeutics for Parkinson's Disease. | Chin J Integr Med | 2020 | https://conductscience.org/library/papers/32476098 | PubMed |
| 7,264,627 | Treatment of Parkinson's disease: problems with a progressing disease. | J Neural Transm | 1981 | https://conductscience.org/library/papers/7264627 | PubMed |
| 7,026,735 | The effect of bromocriptine (BCT) on the on-off phenomenon. | J Neural Transm | 1981 | https://conductscience.org/library/papers/7026735 | PubMed |
| 6,801,913 | Increase in noradrenaline-synthesizing enzyme activity in medulla oblongata in Parkinson's disease. | Acta Neuropathol | 1982 | https://conductscience.org/library/papers/6801913 | PubMed |
| 6,192,438 | A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6192438 | PubMed |
| 3,100,965 | Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study. | Naunyn Schmiedebergs Arch Pharmacol | 1986 | https://conductscience.org/library/papers/3100965 | PubMed |
| 3,063,495 | Therapeutic applications of bromocriptine in endocrine and neurological diseases. | Drugs | 1988 | https://conductscience.org/library/papers/3063495 | PubMed |
| 2,651,567 | Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group. | J Neurol Neurosurg Psychiatry | 1989 | https://conductscience.org/library/papers/2651567 | PubMed |
| 2,647,907 | The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years. | J Neurol Neurosurg Psychiatry | 1989 | https://conductscience.org/library/papers/2647907 | PubMed |
| 720,482 | Antiparkinsonian drug doses and neuroleptic receptors. | Experientia | 1978 | https://conductscience.org/library/papers/720482 | PubMed |
| 591,982 | Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/591982 | PubMed |
| 501,350 | Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading. | J Neural Transm | 1979 | https://conductscience.org/library/papers/501350 | PubMed |
| 490,153 | EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. | J Neural Transm | 1979 | https://conductscience.org/library/papers/490153 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GH1 | 2,688 | PubTator's text mining | https://conductscience.org/library/genes/2688 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/772175
GET https://conductscience.org/api/papers/v1/772175/cited_by?page=2